MedPath
NMPA Approval

Budesonide and Formoterol Fumarate Powder for Inhalation(II)

国药准字HJ20140457

February 23, 2024

H20140457

Drug Information

布地奈德福莫特罗吸入粉雾剂(Ⅱ)

信必可都保

吸入粉雾剂

每支120吸,每吸含布地奈德160μg和富马酸福莫特罗4.5μg

化学药品

February 23, 2024

February 22, 2029

Company Information

Applicant Company

ASTRAZENECA AB

SE-151 85 Södertälje, Sweden

Manufacturing Company

ASTRAZENECA AB

Forskargatan 18, SE-151 36 Södertälje, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.